Neurostimulation Systems with Advanced Flexible Circuit Assemblies
Legal Citation
Summary of the Inventive Concept
This inventive concept discloses next-generation neurostimulation systems that integrate advanced flexible circuit assemblies with nanoscale materials, 3D-printed substrates, and machine learning algorithms to optimize treatment outcomes for neurological disorders.
Background and Problem Solved
The original patent addressed sympathetic nerve modulation using medical devices with flexible circuit assemblies. However, these devices have limitations in terms of their size, material properties, and ability to adapt to real-time neural activity feedback. The new inventive concept solves these problems by introducing advanced flexible circuit assemblies that enable more precise and personalized neural stimulation.
Detailed Description of the Inventive Concept
The neurostimulation system comprises a neural interface module, a flexible circuit assembly, and a control unit. The flexible circuit assembly integrates a nanoscale material and a 3D-printed substrate, allowing for increased precision and adaptability. The control unit adjusts stimulation parameters based on real-time neural activity feedback from the neural interface module. The system can be implanted or worn externally, and can be powered wirelessly using a power harvesting module. The system's adaptability is further enhanced by machine learning algorithms that optimize treatment outcomes.
Novelty and Inventive Step
The new inventive concept introduces several novel features, including the use of nanoscale materials, 3D-printed substrates, and machine learning algorithms to optimize treatment outcomes. These features provide a significant improvement over the original patent, enabling more precise and personalized neural stimulation.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include the use of different nanoscale materials, substrate designs, or machine learning algorithms. Additionally, the system could be adapted for use in other medical applications, such as cardiac rhythm management or neuromuscular therapy.
Potential Commercial Applications and Market
The neurostimulation system has significant commercial potential in the medical device industry, particularly in the areas of neurological disorder treatment and neural modulation. The system's adaptability and precision make it an attractive solution for patients and healthcare providers seeking more effective treatment options.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61B18/1492 |
| A | A61 | A61F7/007 |
| A | A61 | A61F7/123 |
| H | H05 | H05K1/028 |
| A | A61 | A61B2018/0016 |
| A | A61 | A61B2018/0022 |
| A | A61 | A61B2018/00404 |
| A | A61 | A61B2018/00434 |
| A | A61 | A61B2018/00511 |
| A | A61 | A61B2018/00577 |
| A | A61 | A61B2018/00797 |
| A | A61 | A61B2018/00815 |
| A | A61 | A61B2018/1465 |
| A | A61 | A61B2018/1467 |
| A | A61 | A61B2018/1475 |
| A | A61 | A61F2007/126 |
Original Patent Information
| Patent Number | US 11,857,148 |
|---|---|
| Title | Medical devices with flexible circuit assemblies |
| Assignee(s) | Boston Scientific Scimed, Inc. |